Ron Renaud

Biotech executive and CEO of Kylara Therapeutics, experienced leader with prior companies acquired by Merck, Sanofi, and AbbVie, now leading development of GLP-1–based medicines for obesity.

Best podcasts with Ron Renaud

Ranked by the Snipd community

Jan 22, 2026 • 1h 5min

Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines

Ron Renaud, CEO of Kylara Therapeutics and seasoned biotech leader, shares insights on developing GLP-1 medicines designed to combat obesity. He discusses the pivotal moment for GLP-1 treatments, highlighting impressive phase 2 results of rebupatide and its unique advantages over competitors. Renaud explains the significance of tolerability and market differentiation while outlining Kylara's focus on high-BMI patients. The conversation also touches on the societal impact of obesity treatments and the promising potential within this evolving healthcare landscape.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app